(TheNewswire)



Click Image To View Full Size

MISSISSAUGA, Ontario TheNewswire – February 9, 2021 Sire Bioscience Inc. (CSE:SIRE) (OTC:BLLXF) (FSE:BR1B) (“ Sire ” or the “ Company ”) is pleased to announce that it has entered into a non-binding letter of intent (the “ LOI ”) to acquire 100% of Denver-based PlantFuel, Inc. (“ PlantFuel ”) for 65,000,000 common shares of the Company (the “ Common Shares ”), with an ascribed value of CAD$0.15 per common share, subject to due diligence, entering into a definitive agreement and other customary closing conditions, including the approval of the Canadian Securities Exchange.

Under the proposed terms of the LOI, the management team at PlantFuel would continue on and the current shareholders of PlantFuel would have the right to nominate one additional member to the Board of Directors of the Company.

Brian Polla, CEO, COO and a director of the Company commented:  “ PLANTFUEL® is a Science-Driven, Athlete-Focused, PLANT FUELED Nutrition Company. Its team is led by industry veterans who have driven companies in the nutraceutical and supplement spaces to over $1B in combined revenues.  PlantFuel believes that rooted within the core of every athlete is the desire to improve—be it a drive to be stronger, faster, or healthier, the craving to Keep Going™ always endures. PlantFuel’s commitment to consumers is to create the best products available, to successfully bridge the gap between healthy, plant-based nutrition and peak performance.”

In pursuit of its quest to become the world’s first PLANT FUELED athlete-focused company, PlantFuel utilizes a multi-approach: a scientific process including world-class physician formulations, using clinically proven, banned substance-free ingredients that do not compromise on flavor, digestion quality, or performance output.

PlantFuel aims to be “Good for the Body, as well as Good for the Planet.” The packaging is made from plants that are compostable and responsibly sourced. Products are packed in plastic-free, PLANT FUELED packaging. A portion of proceeds from every sale of PlantFuel products will be donated to One Tree Planted, a non-profit organization focused on global reforestation, protecting biodiversity, and creating a healthier climate.”

As an additional condition of the proposed transaction, the Company would be required to complete a concurrent non-brokered private placement (the “ Private Placement ”) for gross proceeds of at least $3,000,000. The Company intends to use the proceeds from the Private Placement to advance the Company’s current products, to develop the PlantFuel business, for working capital and for general corporate purposes.

All securities issued will be subject to a four-month hold period pursuant to securities laws in Canada.

The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

About Sire Bioscience Inc.

SIRE is headquartered in Mississauga, Ontario, and is managed by a group of successful entrepreneurs who have extensive experience in the areas of consumer-packaged goods, manufacturing, logistics, and distribution. SIRE is a CPG life science company focused on the plant-based foods and supplements industry.

FOR INFORMATION, CONTACT:

Sire Bioscience Inc.

E: ir@sirebioscience.com

CEO: Brian Polla (416) 669-9392

Website: sirebioscience.com

Socials: @sirebioscience

Forward‐Looking Information Cautionary Statement

This press release contains certain “forward‐looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward‐looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward‐looking information and forward‐looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward‐looking information or forward‐looking statements can be identified by the use of forward‐looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements.

An investment in securities of the Company is speculative and subject to several risks including, without limitation, the risks discussed under the heading “Risks Factors” in the Company’s Listing Statement dated August 22, 2019 and filed on the Company’s SEDAR profile. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward‐looking information and forward‐looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended.

In connection with the forward‐looking information and forward‐looking statements contained in this press release, the Company has made certain assumptions. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward‐looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward‐looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward‐looking information and forward‐looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward‐looking information and/or forward‐looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward‐looking information and statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by this notice.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN

Copyright (c) 2021 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less